Cosmo Pharmaceuticals N.V. (FRA:C43)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,853	1,089	879	1,015	1,065	1,136
Market Cap Growth	79.45%	23.93%	-13.36%	-4.76%	-6.21%	10.07%
Enterprise Value	1,736	961	838	974	1,028	1,067
Last Close Price	116.00	65.15	51.15	56.96	55.88	69.40
PE Ratio	30.89	8.18	-	58.91	49.16	-
PS Ratio	10.17	4.08	9.48	9.94	16.37	18.64
PB Ratio	3.97	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	17.30	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	27.35	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	25.21	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	9.51	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	21.35	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	25.21	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	25.62	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	8.80%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	12.20%	24.90%	-0.40%	5.00%	1.40%	0.30%
Earnings Yield	3.24%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	3.66%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	1.81%	3.15%	3.91%	1.84%	1.70%	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	0.16%	1.21%	5.86%	4.67%	-15.11%	1.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.